Compare Arm Holdings plc (ARM) vs Tilray Brands Inc (TLRY) Price & Performance

Arm Holdings plcTrade

Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Arm Holdings plc vs Tilray Brands Inc — how do they compare? Arm Holdings plc trades at $298.37 (market cap $345.41B), while Tilray Brands Inc trades at $4.53 (market cap $544.44M). The key difference: Arm Holdings plc is far larger — about 634.4× Tilray Brands Inc's market cap, and Arm Holdings plc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

	ARM	TLRY
Market Cap	$345.41B	$544.44M
Sector	Technology	Health
52-Week High	$439.46	$21.00
52-Week Low	$104.55	$4.31
Enterprise Value	$342.26B	$641.59M

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Arm Holdings plc

ARM Holdings trades at $323.39, down 1.37% over 24 hours, with a bullish technical outlook supported by moving averages and strong quarterly earnings beats. The company reported robust revenue growth to $4.01B in 2025, with net income of $792M, though valuation ratios like P/E of 380.46 reflect premium pricing. Recent news highlights ARM's role in AI infrastructure and data center expansion, driving investor optimism.

Outlook remains positive with analyst consensus favoring buy ratings (74.07%) and a $321.65 price target, but risks include high valuation sensitivity and competitive pressures in the semiconductor space. Upside potential hinges on continued AI-driven demand and execution of growth initiatives like the AGI CPU launch.

Tilray Brands Inc

TLRY trades at $4.42, up 0.68% on the day, with a bearish technical outlook and mixed fundamentals. The stock shows low valuation ratios (P/S 0.55, P/B 0.35) but deep losses (net margin -156.67%) and negative cash flow from operations. Recent news highlights expansion in medical cannabis and new product launches, yet earnings misses and high debt-to-asset ratios signal ongoing challenges.

Outlook remains uncertain with profitability elusive; growth via acquisitions adds scale but not earnings. Analyst consensus is cautious (25% buy, 65% hold), reflecting skepticism about near-term turnaround. Key risks include sustained cash burn, competitive pressures, and regulatory hurdles in the cannabis sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARM

REX AI Equity Premium Income ETF shifts to weekly payouts, but income sustainability is uncertain.24/7 Wall Street · 16 hours agoNeutral Global Edge AI semiconductor market to reach $151.3B by 2035, driven by AI adoption in devices and industries.Sns Insider · 3 days agoBullish Micron boosts US semiconductor supply chain with $3B investment and $500M for wafer expansionCNBC · 4 days agoBullish View details →

TLRY

Tilray Medical launches its first medical cannabis product in Panama, expanding access in Latin America.GlobeNewsWire · 3 days agoBullish Breckenridge Distillery launches Breck Vodka Seltzer in four flavors at 5% ABV, expanding into ready-to-drink market.GlobeNewsWire · 4 days agoBullish View details →

About Arm Holdings plc

Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.